(IN BRIEF) Empa and HOCH Health Ostschweiz have launched a research project to develop nanozyme-based therapies for treating aggressive brain tumors such as astrocytoma, using near-infrared light to activate the treatment directly at the tumor site. The approach aims to … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Switzerland, Technology
Tagged astrocytoma, blood-brain barrier, brain tumors, cancer research, Empa, Empa and HOCH Health Ostschweiz Explore Innovative Nanotherapy to Improve Brain Cancer Outcomes, Giacomo Reina, Hedy Glor Meyer Foundation, HOCH Health Ostschweiz, Isabel Hostettler, nanomedicine, nanozymes, Near Infrared Activated Nanozymes Offer New Hope for Precision Brain Tumor Treatment, near infrared light therapy, oncology innovation, Swiss Cancer Foundation, targeted therapy
(IN BRIEF) The World Economic Forum’s 2025 Top 10 Emerging Technologies report, produced with Frontiers, identifies ten innovations ready for deployment within three to five years. Addressing global challenges in urban mobility, online trust, sustainable production, healthcare, and clean energy, … Read the full press release
Posted in Business, Environment, Financial, Government, Industrial, Investment, Management, Marketing, Media, News, Switzerland, Technology
Tagged advanced nuclear technologies, AMNC25, Annual Meeting of the New Champions, autonomous biochemical sensing, collaborative sensing, energy-material convergence, engineered living therapeutics, Frederick Fenter, Frontiers, generative watermarking, GLP-1 neurodegenerative therapies, green nitrogen fixation, human health, Jeremy Jurgens, nanozymes, osmotic power systems, partnership, real-world impact, structural battery composites, sustainability, sustainable industry, Tianjin, Top 10 Emerging Technologies, trust and safety, World Economic Forum
(IN BRIEF) An international team of researchers, including Empa scientists, is developing nanozymes to treat inflammation during pregnancy without harming the mother or fetus. These tiny particles, which have enzyme-like properties, could provide a safer alternative to traditional medications. Initial … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Switzerland, Technology
Tagged anti-inflammatory, antibacterial, biotechnology, Empa, Empa research, fetal health, Healthcare Innovation, human placental tissue, inflammation, maternal health, nanomedicines, nanotechnology, nanozymes, Nikolaos Tagaras, placenta chip, placental barrier, pregnancy complications, pregnancy research, prenatal care, safe treatment, Swiss National Science Foundation, Tina Bürki
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?